Versant Venture Management, LLC Long-Term Concentrated

CIK: 0001560009 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: Apr 28, 2020

Total Value ($000): $364,636,407 (100.0% shares, 0.0% debt)

Holdings (9)

CRSP CRISPR Therapeutics AG 48.6%

Value ($000) $177,224,616 Shares 4,205,615 Est. Cost $40.26 Unrealized +28.2%

— Adverum Biotechnologies, Inc. 18.9%

Value ($000) $69,056,636 Shares 7,068,233 Est. Cost $9770.00 Unrealized —

— Akero Therapeutics, Inc. 15.9%

Value ($000) $58,015,326 Shares 2,736,572 Est. Cost $21200.00 Unrealized —

VCYT Veracyte, Inc. 8.0%

Value ($000) $29,303,444 Shares 1,205,407 Est. Cost $11.03 Unrealized +128.2%

— Gritstone Oncology, Inc. 5.0%

Value ($000) $18,059,047 Shares 3,102,929 Est. Cost $11140.00 Unrealized —

OCUL Ocular Therapeutix, Inc. 3.0%

Value ($000) $10,966,151 Shares 2,215,384 Est. Cost $20.09 Unrealized -75.4%

— CymaBay Therapeutics, Inc. 0.2%

Value ($000) $804,754 Shares 543,753 Est. Cost $9871.60 Unrealized —

— Clovis Oncology, Inc. 0.2%

Value ($000) $647,798 Shares 101,855 Est. Cost $56000.00 Unrealized —

— Second Sight Medical Products, Inc. 0.2%

Value ($000) $558,635 Shares 561,612 Est. Cost $1210.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CRSP	CRISPR Therapeutics AG	4,205,615	$177,224,616	48.6%	$40.26	+28.2%	Common Stock	H17182108
—	Adverum Biotechnologies, Inc.	7,068,233	$69,056,636	18.9%	$9770.00	—	Common Stock	00773U108
—	Akero Therapeutics, Inc.	2,736,572	$58,015,326	15.9%	$21200.00	—	Common Stock	00973Y108
VCYT	Veracyte, Inc.	1,205,407	$29,303,444	8.0%	$11.03	+128.2%	Common Stock	92337F107
—	Gritstone Oncology, Inc.	3,102,929	$18,059,047	5.0%	$11140.00	—	Common Stock	39868T105
OCUL	Ocular Therapeutix, Inc.	2,215,384	$10,966,151	3.0%	$20.09	-75.4%	Common Stock	67576A100
—	CymaBay Therapeutics, Inc.	543,753	$804,754	0.2%	$9871.60	—	Common Stock	23257D103
—	Clovis Oncology, Inc.	101,855	$647,798	0.2%	$56000.00	—	Common Stock	189464100
—	Second Sight Medical Products, Inc.	561,612	$558,635	0.2%	$1210.00	—	Common Stock	81362J100